Dutasteride/tamsulosin - EMS
Alternative Names: DTT-106Latest Information Update: 08 Mar 2024
At a glance
- Originator EMS
- Class Amines; Antiandrogens; Azasteroids; Benzene derivatives; Ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Cholestenone 5 alpha-reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Erectile dysfunction
Most Recent Events
- 20 Feb 2024 Preclinical trials in Erectile dysfunction in Brazil (PO)
- 20 Feb 2024 EMS plans the phase III AUSTRÁLIA trial for Erectile dysfunction in Brazil (PO, Capsule) in February 2025 (NCT06264414)